BIOSPRING THE NUCLEIC ACID COMPANY
LIVE

Serial Number

97099607

Owner

BioSpring Gesellschaft für Biotechnologie GmbH

Attorney

Julie A. Katz

First Use Date

Apr 30, 2017

Filing Date

Oct 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BIOSPRING THE NUCLEIC ACID COMPANY Trademark

Serial Number: 97099607 • Registration: 7375011

BIOSPRING THE NUCLEIC ACID COMPANY is a trademark filed by BioSpring Gesellschaft für Biotechnologie GmbH on October 29, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BioSpring Gesellschaft für Biotechnologie GmbH (2 trademarks)

Alt-Fechenheim 34
Frankfurt 60386 , DE

Entity Type: 16

BioSpring Gesellschaft für Biotechnologie mbH (3 trademarks)

Alt Fechenheim 34

Entity Type: 99

Trademark Details

Filing Date

October 29, 2021

Registration Date

April 30, 2024

First Use Anywhere

April 30, 2017

First Use in Commerce

April 30, 2017

Published for Opposition

November 8, 2022

Goods & Services

Nucleic acid for medical diagnostic purposes; Oligonucleotides for medical diagnostic purposes; Oligonucleotides for pharmaceutical purposes

Nucleic acid for laboratory or research use; Nucleic acid for use in the manufacture of pharmaceuticals; Oligonucleotides for laboratory or research use; Oligonucleotides for use in the manufacture of pharmaceuticals

Scientific research services, namely, nucleic acid analysis; Scientific research services, namely, oligonucleotide analysis

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 26, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 25, 2024 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 7, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 12, 2024 GNFN
FINAL REFUSAL E-MAILED
Feb 12, 2024 GNFR
SU - FINAL REFUSAL - WRITTEN
Feb 12, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2024 CRFA
ASSIGNED TO LIE
Jan 16, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Aug 21, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jul 25, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 25, 2023 AITU
USE AMENDMENT FILED
Jul 3, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 3, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 3, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 19, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2022 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Aug 16, 2022 GPRN
PRIORITY ACTION E-MAILED
Aug 16, 2022 GPRA
PRIORITY ACTION WRITTEN
Aug 16, 2022 CPRA
ASSIGNED TO EXAMINER
Aug 9, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 11, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 10, 2021 NWOS
NEW APPLICATION ENTERED
Nov 2, 2021 NWAP